Omega 6 Benefits, with comments by Dr. Gordon
By Linda on Dec 1, 2011 in F.I.G.H.T., Food
Dr. Gordon’s comments:
This is important research documenting the benefits of Omega-6 by looking at Arterial stiffness. This form of documentation of benefits is what we used 35 years ago when I wrote the Chelation protocol still widely used around the world today.
I have always insisted that Beyond Chelation Improved could not have eliminated fatal heart attacks, as well as it has, unless there were important synergies in the over 100 active ingredients found in the nine pill packets taken ideally twice a day.
Please understand you are as old as your arteries and preventing or even just slowing arterial stiffness is real anti-aging medicine! I hope you understand that I also work to keep bones strong, i.e. calcified and arteries soft, i.e. not calcified. That has been my Anti-aging focus for over 35 years so please read up on pathological calcification and K-2 and the rest of what I have written about extensively now for years.
Measuring arterial stiffness is a useful part of anti-aging medicine and keeps patients interested in staying on a comprehensive program to stay younger. There are great affordable devices today that accomplish this. Check out International Anti-aging Systems or IAS for their great affordable instrument that boils this down to VASCULAR AGE. You can make patients arteries many years younger over time predictably with the programs I have written about both oral and or IV but this is a lifetime program!!
Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com
Link: http://www.nutritionaloutlook.
Excerpt:
Australian researchers pooled results of 10 randomized and controlled adult human clinicals investigating the effects of omega-3 supplementation on arterial stiffness. Trials ranged from 6 to 105 weeks in duration, with supplementation of 640 to 3000 mg of combined omega-3 eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in the form of daily capsules. A total of 550 participants were included in the meta-analysis, ranging from healthy men to subjects with various cardiovascular conditions, including overweight, diabetes, and hypertension.
